<![CDATA[Alvotech 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=32027>Sat, 18 Apr 2026 16:52:50 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Alvotech, a Global Pureplay Biosimilars Company, to Debut on Nasdaq Under the Ticker ALVO on June 16]]>https://www.newswire.co.kr/newsRead.php?no=946355Thu, 16 Jun 2022 15:50:00 +0900<![CDATA[알보텍, 종목코드 ALVO로 16일 나스닥 상장… 글로벌 순수 바이오시밀러 기업으로 재도약]]>https://www.newswire.co.kr/newsRead.php?no=946356Thu, 16 Jun 2022 15:50:00 +0900<![CDATA[Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie]]>https://www.newswire.co.kr/newsRead.php?no=942407Thu, 07 Apr 2022 16:30:00 +0900<![CDATA[알보텍과 스타다, 애브비와 유럽 특허 분쟁 매듭으로 구연산염 제거 고농도 휴미라 바이오시밀러 HUKYNDRA®(AVT02) 출시 가능해져]]>https://www.newswire.co.kr/newsRead.php?no=942411Thu, 07 Apr 2022 16:30:00 +0900<![CDATA[Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira®]]>https://www.newswire.co.kr/newsRead.php?no=940731Thu, 10 Mar 2022 09:40:00 +0900<![CDATA[알보텍, 애브비와 고농도 휴미라 바이오시밀러(AVT02) 특허 및 영업 비밀 분쟁 매듭]]>https://www.newswire.co.kr/newsRead.php?no=940732Thu, 10 Mar 2022 09:40:00 +0900<![CDATA[FDA Accepts Alvotech’s BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira®]]>https://www.newswire.co.kr/newsRead.php?no=940307Wed, 02 Mar 2022 10:15:00 +0900<![CDATA[Alvotech Initiates Clinical Studies for AVT04, a Proposed Biosimilar to Stelara® (Ustekinumab)]]>https://www.newswire.co.kr/newsRead.php?no=926708Wed, 07 Jul 2021 14:00:00 +0900<![CDATA[알보텍, ‘스텔라라’(우수테키누맙)의 제안된 바이오시밀러인 AVT04에 대한 임상시험 개시]]>https://www.newswire.co.kr/newsRead.php?no=926709Wed, 07 Jul 2021 14:00:00 +0900<![CDATA[Alvotech Disputes AbbVie’s Recent Allegations]]>https://www.newswire.co.kr/newsRead.php?no=920677Fri, 26 Mar 2021 16:20:00 +0900<![CDATA[알보텍, 애브비 주장 혐의에 이의 제기]]>https://www.newswire.co.kr/newsRead.php?no=920678Fri, 26 Mar 2021 16:20:00 +0900<![CDATA[Fuji Pharma Invests in Alvotech for US$50 Million]]>https://www.newswire.co.kr/newsRead.php?no=880943Tue, 18 Dec 2018 18:20:00 +0900<![CDATA[후지제약, 알보텍에 5000만달러 투자]]>https://www.newswire.co.kr/newsRead.php?no=880945Tue, 18 Dec 2018 18:20:00 +0900<![CDATA[Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan]]>https://www.newswire.co.kr/newsRead.php?no=879302Tue, 20 Nov 2018 13:45:00 +0900<![CDATA[알보텍과 후지제약, 바이오시밀러의 일본 내 개발 및 상용화 위해 독점적 파트너십 계약 체결]]>https://www.newswire.co.kr/newsRead.php?no=879303Tue, 20 Nov 2018 13:45:00 +0900